险资方向，本期较上一期持股增加的险资共计1个，即新华资管-兴业银行-新华资产-明汇二号资产管理 产品，持股增加占比达0.1%。 公募基金方面，本期较上一期持股增加的公募基金共计2个，包括富国中证旅游主题ETF、华夏中证旅 游主题ETF，持股增加占比达0.32%。本期较上一季未再披露的公募基金共计74个，主要包括华夏回报 混合A、鹏华优质治理混合(LOF)A、圆信永丰兴诺、诺安平衡混合A、鹏华产业精选混合A等。 2025年10月25日，君亭酒店(301073.SZ)发布2025年第三季报。截至2025年10月24日，共有3个机构投资 者披露持有君亭酒店A股股份，合计持股量达293.89万股，占君亭酒店总股本的1.51%。其中，机构投 资者包括中国银行股份有限公司-富国中证旅游主题交易型开放式指数证券投资基金、新华资管-兴业银 行-新华资产-明汇二号资产管理产品、中国银行股份有限公司-华夏中证旅游主题交易型开放式指数证券 投资基金，机构投资者合计持股比例达1.51%。相较于上一季度，机构持股比例合计下跌了1.20个百分 点。 ...

Group 1 - Kanyuan Pharmaceutical (600557.SH) released its 2024 annual report on April 3, 2025, indicating that 125 institutional investors disclosed holding A-shares, totaling 292 million shares, which accounts for 50.25% of the total share capital [1] - The top ten institutional investors include Jiangsu Kanyuan Group Co., Ltd., Lianyungang Kangbeier Medical Equipment Co., Ltd., Central Huijin Asset Management Co., Ltd., and others, with a combined holding ratio of 47.38%, showing a decrease of 1.85 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, five funds reported a decrease in holdings compared to the previous quarter, with a total reduction of 1.49% [2] - A total of 111 new public funds were disclosed this period, including funds such as Rongtong Health Industry Flexible Allocation Mixed A/B and Southern CSI 1000 ETF [2] - Four public funds were not disclosed this period, including various funds under the Fangzheng Fubang brand [2]